synergy nash tirzepatide Nearly 62% achieve MASH resolution without worsening of fibrosis with In the SYNERGY-NASH trial, researchers

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field

But the weight you lose isn't just fat

A common cold shouldn't automatically stop your tirzepatide therapy, but timing and symptoms matter

Iron also forms part of myoglobin, a prote

Oral anti-hyperglycemic medications, other than sulfonylureas and SGLT2 inhibitors, provide a reasonable alternative to insulin and can be continued safely perioperatively depending upon the type of surgery and the patient is expected to resume oral intake soon postoperatively.